Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10895635 | 0.89 | TSHR (0.59) | TSHRALOX15TDP1ALDH1A1KDM4E | |
| SCHEMBL6392102 | 0.81 | ALOX15 (0.48) | TSHRALOX15TDP1ALDH1A1KDM4E | |
| SCHEMBL10829097 | 0.76 | TSHR (0.50) | TSHR | |
| SCHEMBL194752 | 0.75 | TSHR (1.00) | TSHRALOX15TDP1ALDH1A1 | |
| SCHEMBL29376586 | 0.75 | TSHR (1.00) | TSHRALOX15TDP1ALDH1A1 | |
| SCHEMBL31037900 | 0.74 | TYMS (0.46) | TSHRALOX15TDP1 | |
| SCHEMBL22605624 | 0.74 | TYMS (0.46) | TSHRALOX15TDP1 | |
| Ammonia Solution, Strong SCHEMBL7773774 | 0.73 | TSHR (0.94) | TSHRALOX15TDP1ALDH1A1 | |
| SCHEMBL38664107 | 0.73 | TSHR (0.94) | TSHRALOX15TDP1ALDH1A1 | |
| Magnesium SCHEMBL31583965 | 0.73 | TSHR (0.94) | TSHRALOX15TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2438106-B1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | BOEING CO (US) | 2015-03-11 | — | — | EP | disclosed |
| EP-2438106-A1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | The Boeing Company (US) | 2012-04-11 | — | — | EP | disclosed |
| US-8106142-B2 | Polyacetylinic oligomers | THE BOEING COMPANY (US) | 2012-01-31 | — | — | US | disclosed |
| US-8063168-B2 | Oligomers with di-phenylethynyl endcaps | THE BOEING COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| WO-2010141106-A1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | THE BOEING COMPANY (US) | 2010-12-09 | — | — | WO | disclosed |
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | THE BOEING COMPANY | 2010-08-12 | — | — | US | disclosed |
| US-20100204412-A1 | OLIGOMERS WITH DI-PHENYLETHYNYL ENDCAPS | THE BOEING COMPANY | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | AADAC, ACMSD, ECPAS | TSHR 4437/4885ALOX15 1581/4885TDP1 1544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.